# clarify_device_type PRD

## Description
Identify the appropriate device type, e.g., Class I, II, or III, and determine any specific regulations or requirements that apply.


## Implementation Plan

### 1. Collect all relevant device attributes (intended use, indications, technology, performance metrics, and risk factors) from the product data repository or user input forms.

| Category | Details |
| --- | --- |
| **Reason** | These attributes provide the foundational information needed to map the device to FDA risk categories and classification criteria. |
| **Impact** | HIGH |
| **Complexity** | MEDIUM |
| **Method** | Implement a data ingestion module that parses structured product specifications (JSON/XML) and validates required fields. Prompt the user for missing attributes via a guided questionnaire. |

### 2. Map the collected attributes to FDA risk categories (low, moderate, high) using the risk tables defined in 21 CFR Part 801.

| Category | Details |
| --- | --- |
| **Reason** | Risk level directly influences the device class determination. |
| **Impact** | HIGH |
| **Complexity** | MEDIUM |
| **Method** | Create lookup tables that associate specific technology types, intended uses, and performance thresholds with risk levels. Apply a scoring algorithm that aggregates attribute scores to produce a single risk category. |

### 3. Determine the device class by cross‑referencing the risk category with FDA classification criteria (Class I for low risk, Class II for moderate risk, Class III for high risk).

| Category | Details |
| --- | --- |
| **Reason** | Ensures the classification aligns with regulatory definitions. |
| **Impact** | HIGH |
| **Complexity** | LOW |
| **Method** | Use straightforward conditional logic: if risk == 'low' then class = 'Class I'; if risk == 'moderate' then class = 'Class II'; else class = 'Class III'. |

### 4. Retrieve the specific regulatory requirements for the determined class by consulting FDA guidance documents, 21 CFR subparts, and pre‑market notification requirements (e.g., 510(k), PMA, De Novo).

| Category | Details |
| --- | --- |
| **Reason** | Provides the downstream node with the exact compliance checklist needed for documentation and submission. |
| **Impact** | MEDIUM |
| **Complexity** | MEDIUM |
| **Method** | Leverage the FDA Regulatory Information API or web‑scrape the FDA website to fetch relevant guidance titles and subpart references. Filter results by the identified class and store them as a list of strings. |

### 5. Calculate a classification confidence score by evaluating data completeness, consistency with classification criteria, and presence of ambiguous attributes.

| Category | Details |
| --- | --- |
| **Reason** | Offers an audit trail and helps downstream processes decide whether expert review is needed. |
| **Impact** | MEDIUM |
| **Complexity** | MEDIUM |
| **Method** | Implement a weighted scoring algorithm: assign points for each mandatory attribute present, deduct points for conflicts or missing data, and normalize to a 0‑1 scale. |

### 6. Assemble the output fields (device_class, device_class_code, regulatory_requirements, classification_confidence) into the node’s expected JSON structure.

| Category | Details |
| --- | --- |
| **Reason** | Ensures the node’s contract is fulfilled and downstream nodes receive correctly typed data. |
| **Impact** | LOW |
| **Complexity** | LOW |
| **Method** | Map internal variables to the output keys, convert the class code to its short form (I/II/III), and serialize the list of requirements as an array of strings. |

### 7. Validate the assembled output against the defined schema and perform a cross‑check with the parent node’s expectations (e.g., ensure that regulatory_requirements are non‑empty for Class II/III).

| Category | Details |
| --- | --- |
| **Reason** | Prevents data quality issues that could cascade through the DAG. |
| **Impact** | LOW |
| **Complexity** | LOW |
| **Method** | Run unit tests that assert field types, required fields, and logical consistency. Log any validation failures for manual review. |
